JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (21)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aouad, M. T.
Right arrow Articles by Baraka, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aouad, M. T.
Right arrow Articles by Baraka, A. S.
Related Collections
Right arrow Obstetrics
Right arrow Regional Anesthesia
Anesth Analg 2001;92:401-404
© 2001 International Anesthesia Research Society


OBSTETRIC ANESTHESIA

Does Pregnancy Protect Against Intrathecal Lidocaine-Induced Transient Neurologic Symptoms?

Marie T. Aouad, MD, Sahar S. Siddik, MD, FRCA, Maya I. Jalbout, MD, and Anis S. Baraka, MD, FRCA

Department of Anesthesiology, American University of Beirut, Beirut-Lebanon

Address correspondence and reprint requests to Anis Baraka, MD, FRCA, Professor and Chairman, Department of Anesthesiology, American University of Beirut, PO Box 113-6044, Beirut-Lebanon. Address e-mail to abaraka{at}aub.edu.lb

We investigated the incidence of transient neurologic symptoms (TNS) after the use of hyperbaric lidocaine as compared with hyperbaric bupivacaine in patients undergoing cesarean delivery under spinal anesthesia. Two hundred women scheduled for cesarean delivery were randomly allocated to receive spinal anesthesia with 75 mg hyperbaric lidocaine 5% (n = 100) or 12 mg hyperbaric bupivacaine 0.75% (n = 100). Spinal anesthesia was administered to all patients in the sitting position with a 25-gauge Whitacre needle. The level of sensory blockade, time to full recovery, and intraoperative hemodynamic profile were noted in all patients. The patients were interviewed postoperatively for three consecutive days to detect the occurrence of TNS. The incidence of TNS was zero (95% confidence interval 0%–3%) in both the Lidocaine and the Bupivacaine Groups. Our results indicate that the frequency of postoperative TNS does not exceed 3% in patients undergoing cesarean delivery at term using hyperbaric lidocaine 5% or hyperbaric bupivacaine 0.75%.

Implications: Transient neurologic symptom (TNS) can follow spinal anesthesia and manifests as back pain radiating to the legs, resolving spontaneously. Spinal anesthesia for cesarean delivery was performed with either hyperbaric lidocaine 5% (n = 100) or hyperbaric bupivacaine 0.75% (n = 100). TNS was not noted in any patient.




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
J. T. YaDeau, G. A. Liguori, and V. M. Zayas
The Incidence of Transient Neurologic Symptoms After Spinal Anesthesia with Mepivacaine
Anesth. Analg., September 1, 2005; 101(3): 661 - 665.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
D. Zaric, C. Christiansen, N. L. Pace, and Y. Punjasawadwong
Transient Neurologic Symptoms After Spinal Anesthesia with Lidocaine Versus Other Local Anesthetics: A Systematic Review of Randomized, Controlled Trials
Anesth. Analg., June 1, 2005; 100(6): 1811 - 1816.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
A. Fassoulaki, V. Gatzou, G. Petropoulos, and I. Siafaka
Spread of subarachnoid block, intraoperative local anaesthetic requirements and postoperative analgesic requirements in Caesarean section and total abdominal hysterectomy
Br. J. Anaesth., November 1, 2004; 93(5): 678 - 682.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
D. Meininger, C. Byhahn, P. Kessler, J. Nordmeyer, Y. Alparslan, B. A. Hall, and D. H. Bremerich
Intrathecal Fentanyl, Sufentanil, or Placebo Combined with Hyperbaric Mepivacaine 2% for Parturients Undergoing Elective Cesarean Delivery
Anesth. Analg., March 1, 2003; 96(3): 852 - 858.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
C. C. Buckenmaier III, K. C. Nielsen, R. Pietrobon, S. M. Klein, A. H. Martin, R. A. Greengrass, and S. M. Steele
Small-Dose Intrathecal Lidocaine Versus Ropivacaine for Anorectal Surgery in an Ambulatory Setting
Anesth. Analg., November 1, 2002; 95(5): 1253 - 1257.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
D. C. Campbell, C. M. Riben, M. E. Rooney, L.-A. L. Crone, and R. W. Yip
Intrathecal Morphine for Postpartum Tubal Ligation Postoperative Analgesia
Anesth. Analg., October 1, 2001; 93(4): 1006 - 1011.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
M. C. Schneider and D. J. Birnbach
Lidocaine Neurotoxicity in the Obstetric Patient: Is the Water Safe?
Anesth. Analg., February 1, 2001; 92(2): 287 - 290.
[Full Text] [PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2001 by the International Anesthesia Research Society.